PortfoliosLab logoPortfoliosLab logo
EDD vs. CRMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

EDD vs. CRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Morgan Stanley Emerging Markets Domestic Fund (EDD) and CorMedix Inc. (CRMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EDD achieves a 13.61% return, which is significantly higher than CRMD's -27.77% return. Over the past 10 years, EDD has outperformed CRMD with an annualized return of 5.82%, while CRMD has yielded a comparatively lower -0.74% annualized return.


EDD

1D
-0.52%
1M
7.32%
6M
8.80%
YTD
13.61%
1Y
25.08%
3Y*
18.30%
5Y*
8.49%
10Y*
5.82%

CRMD

1D
-3.11%
1M
-6.25%
6M
10.09%
YTD
-27.77%
1Y
-25.13%
3Y*
29.03%
5Y*
3.74%
10Y*
-0.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EDD vs. CRMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EDD
Morgan Stanley Emerging Markets Domestic Fund
13.61%32.46%8.64%14.09%-14.15%-7.03%-2.84%25.45%-14.09%16.34%
CRMD
CorMedix Inc.
-27.77%43.58%115.43%-10.90%-7.25%-38.76%2.06%12.87%158.00%-67.32%

Correlation

The correlation between EDD and CRMD is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since May 13, 2010

0.11

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EDD vs. CRMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EDD
EDD Risk / Return Rank: 3737
Overall Rank
EDD Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
EDD Sortino Ratio Rank: 4444
Sortino Ratio Rank
EDD Omega Ratio Rank: 4545
Omega Ratio Rank
EDD Calmar Ratio Rank: 2525
Calmar Ratio Rank
EDD Martin Ratio Rank: 2626
Martin Ratio Rank

CRMD
CRMD Risk / Return Rank: 2828
Overall Rank
CRMD Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
CRMD Sortino Ratio Rank: 2828
Sortino Ratio Rank
CRMD Omega Ratio Rank: 2727
Omega Ratio Rank
CRMD Calmar Ratio Rank: 2828
Calmar Ratio Rank
CRMD Martin Ratio Rank: 3030
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EDD vs. CRMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley Emerging Markets Domestic Fund (EDD) and CorMedix Inc. (CRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EDDCRMDDifference
Sharpe ratioReturn per unit of total volatility

+1.97

Sortino ratioReturn per unit of downside risk

+2.37

Omega ratioGain probability vs. loss probability

1.27

0.96

+0.31

Calmar ratioReturn relative to maximum drawdown

1.44

-0.49

+1.93

Martin ratioReturn relative to average drawdown

4.62

-0.75

+5.37

EDD vs. CRMD - Sharpe Ratio Comparison

The current EDD Sharpe Ratio is 1.53, which is higher than the CRMD Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of EDD and CRMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EDD vs. CRMD - Drawdown Comparison

The maximum EDD drawdown since its inception was -59.38%, smaller than the maximum CRMD drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for EDD and CRMD.


Loading charts...

Drawdown Indicators


EDDCRMDDifference

Max Drawdown

Largest peak-to-trough decline

-59.38%

-98.28%

+38.90%

Max Drawdown (1Y)

Largest decline over 1 year

-17.67%

-57.86%

+40.19%

Max Drawdown (3Y)

Largest decline over 3 years

-17.67%

-62.26%

+44.59%

Max Drawdown (5Y)

Largest decline over 5 years

-32.04%

-62.63%

+30.59%

Max Drawdown (10Y)

Largest decline over 10 years

-42.70%

-94.77%

+52.07%

Current Drawdown

Current decline from peak

-2.04%

-82.98%

+80.94%

Average Drawdown

Average peak-to-trough decline

-24.13%

-77.57%

+53.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.50%

37.68%

-32.18%

Volatility

EDD vs. CRMD - Volatility Comparison

The current volatility for Morgan Stanley Emerging Markets Domestic Fund (EDD) is 5.29%, while CorMedix Inc. (CRMD) has a volatility of 14.53%. This indicates that EDD experiences smaller price fluctuations and is considered to be less risky than CRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EDDCRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.29%

14.53%

-9.24%

Volatility (6M)

Calculated over the trailing 6-month period

13.43%

51.46%

-38.03%

Volatility (1Y)

Calculated over the trailing 1-year period

16.67%

63.35%

-46.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.47%

77.14%

-61.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.64%

91.65%

-74.01%

Dividends

EDD vs. CRMD - Dividend Comparison

EDD's dividend yield for the trailing twelve months is around 10.94%, while CRMD has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CRMD
CorMedix Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EDD
Morgan Stanley Emerging Markets Domestic Fund
10.94%9.76%11.45%7.30%6.82%6.93%6.92%8.15%9.90%8.18%10.32%12.65%

Frequently Asked Questions


EDD and CRMD have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CRMD has higher volatility (14.53%) compared to EDD (5.29%). In terms of maximum drawdown, EDD dropped -59.38% vs CRMD's -98.28%.

EDD currently has the higher Sharpe Ratio (1.53 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EDD and CRMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer